Osimertinib Induces Paraptosis and TRIP13 Confers Resistance in Glioblastoma Cells

Scientists demonstrated that Osimertinib induced paraptosis in glioblastoma cells, as evidenced by the formation of cytoplasmic vacuoles, accumulation of ubiquitinated proteins, and upregulation of endoplasmic reticulum stress markers like CHOP.